KIMMTRAK

tebentafusp · Immunocore Commercial LLC

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for KIMMTRAK, covering 2022-01-25 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Tebentafusp for Uveal Melanoma [Phase 2]